JKJeong Ah Kim

Jeong Ah Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jeong Ah Kim has a total of 63 co-authors. Here are the top co-authors by number of shared publications:

  • Kyurim Paek

    Korea Basic Science Institute, 169-148 Kwahak-ro, Daejeon, Daejeon, 34133, Korea (the Republic of)

    8 shared publications
  • Min Kyeong Kim

    Korea Basic Science Institute, 169-148 Kwahak-ro, Daejeon, Daejeon, 34133, Korea (the Republic of)

    5 shared publications
  • Sang-Mi Woo

    Korea Basic Science Institute, 162 Yeongudanji-ro, Daejeon, 34133, Korea (the Republic of)

    4 shared publications
  • Seok Chung

    School of Mechanical Engineering, Korea University, 145 Anam-ro, Seoul, 02841, Korea (the Republic of)

    4 shared publications
  • Won Jong Rhee

    Department of Bioengineering and Nano-Bioengineering, Incheon National University, Incheon, 22012, Republic of Korea

    4 shared publications
  • Jubin Park

    3 shared publications

Latest Publications

  • Open Access

    Novel Drug‐Testing Platform for Vascular Injury‐induced Intimal Hyperplasia Using a Microphysiological System

    by Ungsig Nam, HyeMi Kim, Jeong Ah Kim, Ki‐Hwan Nam, Kye‐Sung Lee, Hwan Hur, Jessie S. Jeon, Ji Yong Bae

    Drug‐coated balloons (DCBs) and drug‐eluting stents (DESs) with antiproliferative drugs have been developed to prevent restenosis. However, some patients who undergo DCB or DES procedures still experience restenosis. Therefore, it is essential to explore therapeutic agents for DCBs and DESs. Furthermore, alternative platforms addressing current experimental model limitations are necessary for disease research. Here, a 3D model of vascular injury‐induced intimal hyperplasia is developed by using a microphysiological system (MPS). This model effectively replicated the endothelial denudation, proliferation, and migration of vascular smooth muscle cells (VSMCs), and vascular inflammation associated with the disease. Using this disease model, it is shown that antiproliferative drugs suppress VSMC proliferation but worsen endothelial denudation. In addition, potential alternatives are investigated to antiproliferative drugs and tested various drugs aimed at reducing inflammation. Partial improvements are found in VSMCs treated with DPI and in the endothelium treated with quercetin. When diphenyleneiodonium (DPI) and quercetin are combined, VSMC proliferation, migration, and vascular inflammation are reduced without impairing re‐endothelialization. This disease model shows promise; this study may offer new treatment insights for DCBs and DESs.

  • A hepatic zonation chip with an oxygen concentration gradient embracing the spatial distribution of metabolic function

    by Min Kyeong Kim, Kyurim Paek, Kyungwon Park, Sungho Tak, Kyuhwan Na, Jung Hoon Choi, Sang-Mi Woo, HanByeol Kim, Yeo Min Yoon, Seok Chung, et al.

    The development of hepatic in vitro models that replicate the physiological characteristics of liver tissue is critical for the accurate translation of drug test results. Current models often fail to mimic the spatial zonation by an oxygen concentration gradient in the hepatic acinus, limiting their ability to predict drug-induced hepatotoxicity. This study aimed to develop a hepatic zonation chip (H-chip) that replicates the oxygen gradient of the hepatic acinus, enhancing physiological relevance for drug testing applications. The H-chip was fabricated with a circular microfabricated chip chamber covered by oxygen-impermeable glass substrates, generating a radial oxygen concentration gradient through oxygen consumption by hepatic cells. This gradient mimics the portal-to-central oxygen distribution observed in vivo, enabling zone-specific hepatic functionality. We showed that the H-chip successfully reproduced the oxygen gradients found in the in vivo hepatic acinus along with corresponding cell cytocompatibility of hepatic cells. Notably, pericentral-specific hepatic functionality increased in the H-chip and decreased in the normoxia chip (N-chip). Spatial transcriptomic analysis revealed heterogeneous gene expression patterns aligned with local metabolic functions in each zone across the H-chip. Furthermore, toxicity evaluation of acetaminophen, a representative drug known for its spatial hepatotoxicity, revealed increased zonation-specific sensitivity in the H-chip, linked to elevated cytochrome P450 gene expression and toxic metabolite formation. These findings highlight the ability of the H-chip to replicate hepatic zonal characteristics, thus providing a robust platform for evaluating hepatotoxicity in drug testing. This platform promises to advance safer and more effective drug development by enabling more physiologically relevant assessments.


  • Open Access

    Development of a BMU-on-a-chip model based on spatiotemporal regulation of cellular interactions in the bone remodeling cycle

    by Sang-Mi Woo, Kyurim Paek, Yeo Min Yoon, Hyang Kim, Serk In Park, Jeong Ah Kim


  • Open Access

    Effects of calciprotein particles on EMT induction in an in vitro 3D‐cultured proximal tubule epithelial cell model of CKD

    by Yeo Min Yoon, Sang‐Mi Woo, Hwanuk Guim, Jeong Ah Kim

    Calciprotein particles (CPPs) are blood‐borne circulating nanoparticles composed of calcium phosphate and proteins that are known to exacerbate pathological processes such as chronic kidney disease‐mineral bone disorder (CKD‐MBD). Despite the significant interest in CKD‐MBD pathogenesis, research directly addressing CPP‐induced fibrosis in renal proximal tubules is rare, largely owing to the lack of suitable in vitro tissue models. Our study confirmed that 3D‐cultured renal proximal tubule epithelial cells (PTECs) exhibited enhanced pathological characteristics compared to 2D‐cultured PTECs when treated with CPPs, a key factor in CKD‐MBD, and the uremic toxin. 3D‐cultured PTECs under CKD‐inducing conditions by CPPs were associated with epithelial–mesenchymal transition (EMT), mediated by transforming growth factor‐β1 (TGF‐β1), with notable changes in early EMT marker expression. Furthermore, this was attributed to increased expression of the calcium‐sensing receptor (CASR), a receptor for CPPs, and activation of the downstream cell division control protein 42 (CDC42), leading to EMT progression. This study underscores the potential of PTEC‐on‐a‐chip systems to serve as drug testing models, given the heightened sensitivity of these cells to external environments. This approach provides a better understanding of the pathological features of CKD and could contribute to the development of more effective in vitro models and therapeutics.


  • A well plate-based GelMA photo-crosslinking system with tunable hydrogel mechanical properties to regulate the PTH-mediated osteogenic fate

    by Kyurim Paek, Sangwook Woo, Seung Jae Song, Min Kyeong Kim, Keewook Yi, Seok Chung, Jeong Ah Kim

    Versatile and efficient regulation of the mechanical properties of the extracellular matrix is crucial not only for understanding the dynamic changes in biological systems, but also for obtaining precise and effective cellular responses in drug testing. In this study, we developed a well plate-based hydrogel photo-crosslinking system to effectively control the mechanical properties of hydrogels and perform high-throughput assays. We improved cell biocompatibility by using gelatin methacryloyl (GelMA) with a visible light photo-crosslinking method. Multiple cell-laden GelMA hydrogels were simultaneously and uniformly created using multi-arrayed 520 nm light-emitting diodes in a well plate format. The elastic modulus of the hydrogels can be widely adjusted (0.5–30 kPa) using a photo-crosslinking system capable of independently controlling the light intensity or exposure time for multiple samples. We demonstrate the feasibility of our system by observing enhanced bone differentiation of human mesenchymal stem cells (hMSCs) cultured on stiffer hydrogels. Additionally, we observed that the osteogenic fate of hMSCs, affected by the different mechanical properties of the gel, was regulated by parathyroid hormone (PTH). Notably, in response to PTH, hMSCs in a high-stiffness microenvironment upregulate osteogenic differentiation while exhibiting increased proliferation in a low-stiffness microenvironment. Overall, the developed system enables the generation of multiple cell-laden three-dimensional cell culture models with diverse mechanical properties and holds significant potential for expansion into drug testing.


  • A long-term storable gel-laden chip composite built in a multi-well plate enabling in situ cell encapsulation for high-throughput liver model

    by Min Kyeong Kim, Jubin Park, Sungho Tak, Kyurim Paek, Geul Bang, Sang-Mi Woo, Naresh Kumar Ravichandran, Won Gi Hong, Hyun-Wook Kang, Hyang Kim, et al.

    Hydrogels are widely used as scaffold materials for constructing in vitro three-dimensional microphysiological systems. However, their high sensitivity to various external cues hinders the development of hydrogel-laden, microscale, and high-throughput chips. Here, we have developed a long-term storable gel-laden chip composite built in a multi-well plate, which enables in situ cell encapsulation and facilitates high-throughput analysis. Through optimized chemical crosslinking and freeze-drying method (C/FD), we have achieved a high-quality of gel-laden chip composite with excellent transparency, uniform porosity, and appropriate swelling and mechanical characteristics. Besides collagen, decellularized extracellular matrix with tissue-specific biochemical compound has been applied as chip composite. As a ready-to-use platform, in situ cell encapsulation within the gel has been achieved through capillary force generated during gel reswelling. The liver-mimetic chip composite, comprising HepG2 cells or primary hepatocytes, has demonstrated favorable hepatic functionality and high sensitivity in drug testing. The developed fabrication process with improved stability of gels and storability allows chip composites to be stored at a wide range of temperatures for up to 28 d without any deformation, demonstrating off-the-shelf products. Consequently, this provides an exceptionally simple and long-term storable platform that can be utilized for an efficient tissue-specific modeling and various biomedical applications.


  • Open Access

    Prediction of anticancer drug resistance using a 3D microfluidic bladder cancer model combined with convolutional neural network-based image analysis

    by Sungho Tak, Gyeongjin Han, Sun-Hee Leem, Sang-Yeop Lee, Kyurim Paek, Jeong Ah Kim

    Bladder cancer is the most common urological malignancy worldwide, and its high recurrence rate leads to poor survival outcomes. The effect of anticancer drug treatment varies significantly depending on individual patients and the extent of drug resistance. In this study, we developed a validation system based on an organ-on-a-chip integrated with artificial intelligence technologies to predict resistance to anticancer drugs in bladder cancer. As a proof-of-concept, we utilized the gemcitabine-resistant bladder cancer cell line T24 with four distinct levels of drug resistance (parental, early, intermediate, and late). These cells were co-cultured with endothelial cells in a 3D microfluidic chip. A dataset comprising 2,674 cell images from the chips was analyzed using a convolutional neural network (CNN) to distinguish the extent of drug resistance among the four cell groups. The CNN achieved 95.2% accuracy upon employing data augmentation and a step decay learning rate with an initial value of 0.001. The average diagnostic sensitivity and specificity were 90.5% and 96.8%, respectively, and all area under the curve (AUC) values were over 0.988. Our proposed method demonstrated excellent performance in accurately identifying the extent of drug resistance, which can assist in the prediction of drug responses and in determining the appropriate treatment for bladder cancer patients.


  • Bone-on-a-Chip: Biomimetic Models Based on Microfluidic Technologies for Biomedical Applications

    by Min Kyeong Kim, Kyurim Paek, Sang-Mi Woo, Jeong Ah Kim

    With the increasing importance of preclinical evaluation of newly developed drugs or treatments, in vitro organ or disease models are necessary. Although various organ-specific on-chip (organ-on-a-chip, or OOC) systems have been developed as emerging in vitro models, bone-on-a-chip (BOC) systems that recapitulate the bone microenvironment have been less developed or reviewed compared with other OOCs. The bone is one of the most dynamic organs and undergoes continuous remodeling throughout its lifetime. The aging population is growing worldwide, and healthcare costs are rising rapidly. Since in vitro BOC models that recapitulate native bone niches and pathological features can be important for studying the underlying mechanism of orthopedic diseases and predicting drug responses in preclinical trials instead of in animals, the development of biomimetic BOCs with high efficiency and fidelity will be accelerated further. Here, we review recently engineered BOCs developed using various microfluidic technologies and investigate their use to model the bone microenvironment. We have also explored various biomimetic strategies based on biological, geometrical, and biomechanical cues for biomedical applications of BOCs. Finally, we addressed the limitations and challenging issues of current BOCs that should be overcome to obtain more acceptable BOCs in the biomedical and pharmaceutical industries.


  • Open Access

    A high‐throughput biomimetic bone‐on‐a‐chip platform with artificial intelligence‐assisted image analysis for osteoporosis drug testing

    by Kyurim Paek, Seulha Kim, Sungho Tak, Min Kyeong Kim, Jubin Park, Seok Chung, Tai Hyun Park, Jeong Ah Kim

    Although numerous organ‐on‐a‐chips have been developed, bone‐on‐a‐chip platforms have rarely been reported because of the high complexity of the bone microenvironment. With an increase in the elderly population, a high‐risk group for bone‐related diseases such as osteoporosis, it is essential to develop a precise bone‐mimicking model for efficient drug screening and accurate evaluation in preclinical studies. Here, we developed a high‐throughput biomimetic bone‐on‐a‐chip platform combined with an artificial intelligence (AI)‐based image analysis system. To recapitulate the key aspects of natural bone microenvironment, mouse osteocytes (IDG‐SW3) and osteoblasts (MC3T3‐E1) were cocultured within the osteoblast‐derived decellularized extracellular matrix (OB‐dECM) built in a well plate‐based three‐dimensional gel unit. This platform spatiotemporally and configurationally mimics the characteristics of the structural bone unit, known as the osteon. Combinations of native and bioactive ingredients obtained from the OB‐dECM and coculture of two types of bone cells synergistically enhanced osteogenic functions such as osteocyte differentiation and osteoblast maturation. This platform provides a uniform and transparent imaging window that facilitates the observation of cell–cell interactions and features high‐throughput bone units in a well plate that is compatible with a high‐content screening system, enabling fast and easy drug tests. The drug efficacy of anti‐SOST antibody, which is a newly developed osteoporosis drug for bone formation, was tested via β‐catenin translocation analysis, and the performance of the platform was evaluated using AI‐based deep learning analysis. This platform could be a cutting‐edge translational tool for bone‐related diseases and an efficient alternative to bone models for the development of promising drugs.